EU CANCER STRATEGY: HARM REDUCTION OF THE LICIT DRUGS WITH A FOCUS ON SOCIALLY VULNERABLE GROUPS autor: ks | Bře 12, 2023 | Zdravá společnost | 0 komentářů EU CANCER STRATEGY FINAL